Part 1: Nursing EMPOWER: Personalizing Patient Management Through Communication and Education on Advanced or Metastatic HR-Positive, HER2-Negative Breast Cancer

View Activity

PROGRAM CHAIR

Debi Selm-Orr, DNP
Community Palliative Care Nurse Practitioner
VNA of Greater Philadelphia
Philadelphia, PA

PROGRAM OVERVIEW

This online activity is focused on the care of patients with early HR-positive, HER2-negative breast cancer.

TARGET AUDIENCE

This CME initiative is designed to meet the educational needs of oncology nurses, nurse practitioners, and other healthcare providers involved in the treatment of patients with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Describe the unique mechanism of action that CDK4/6 inhibition provides as oral oncolytic agents in advanced or metastatic HR+/HER2-negative breast cancer
  • Review the role of oral CDK4/6 inhibitors in the treatment of advanced or metastatic breast cancer

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this web-based live activity for a maximum of 0.5 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the web-based live activity.

NURSING CREDIT INFORMATION

Purpose: Purpose: This program would be beneficial for nurses involved in the care of patients with breast cancer.
Credits: 0.5 ANCC Contact Hour(s)

ONCC RECERTIFICATION:

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.

ACCREDITATION STATEMENT

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 0.5 contact hours of continuing nursing education of RNs and APNs

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Dr. Selm-Orr is a consultant for Horizon CME. She is also a member of speakers bureaus for Taiho and Amgen.

CME Content Review
The content of this activity was independently peer-reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
Lisa Crenshaw, Senior Program Manager for Med Learning Group, has nothing to disclose.
Nicole Longo, DO, FACOI, Medical Director, Scientific and Medical Services for Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this online activity. To receive CME/CNE credit participants must:
1. Read the CME/CNE information and faculty disclosures.
2. Participate in the online activity.
3. Submit the evaluation form to Med Learning Group.

You will receive your certification via email within 30 days.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement
information at http://medlearninggroup.com/privacy‐policy/

RELEASE DATE: July 26, 2019

EXPIRATION DATE: July 26, 2020

View Activity

Copyright © 2019 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.